Eric M Chi
Overview
Explore the profile of Eric M Chi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Chi E, Feng C, Chow S
J Biopharm Stat
. 2011 Mar;
21(2):342-54.
PMID: 21391006
In clinical research, measurement instruments (or questionnaires) consisting of a number of items (questions) are often used to assess treatment effect, e.g., quality-of-life assessment, and clinical disease activity index. In...
2.
Block G, Zeig S, Sugihara J, Chertow G, Chi E, Turner S, et al.
Nephrol Dial Transplant
. 2008 Mar;
23(7):2311-8.
PMID: 18310602
Background: Adequate control of all four KDOQI biochemical targets for chronic kidney disease, bone and mineral disorder (CKD-MBD), which include parathyroid hormone (PTH), calcium (Ca), phosphorus (P) and Ca x...
3.
Chertow G, Blumenthal S, Turner S, Roppolo M, Stern L, Chi E, et al.
Clin J Am Soc Nephrol
. 2007 Aug;
1(2):305-12.
PMID: 17699221
Active vitamin D derivatives attenuate the severity of secondary hyperparathyroidism but often increase serum calcium (Ca) and phosphorus (P) as a result of enhanced intestinal absorption. The calcimimetic cinacalcet HCl...
4.
Jung S, Chow S, Chi E
J Biopharm Stat
. 2007 Jan;
17(1):35-41.
PMID: 17219754
In nonrandomized trials, patients are not randomly assigned to treatment groups with equal probability. Instead, the probability of assignment varies from patient to patient depending on patients baseline covariates. This...
5.
Collins A, Brenner R, Ofman J, Chi E, Stuccio-White N, Krishnan M, et al.
Am J Kidney Dis
. 2005 Sep;
46(3):481-8.
PMID: 16129210
Background: It is unknown to what degree physicians adjust erythropoietin doses to achieve hemoglobin levels (11.0 to 12.0 g/dL [110 to 120 g/L]) recommended by the National Kidney Foundation-Kidney Disease...
6.
Shukla U, Chi E, Lehr K
Ann Pharmacother
. 2004 Jan;
38(1):30-5.
PMID: 14742789
Background: Type 2 diabetes is a global concern, accounting for the vast majority of cases of diabetes. Type 2 diabetes is associated with insulin deficiency and insulin resistance and, increasingly,...